New hope for kids in shock: drug trial targets stubborn low blood pressure
Disease control
ENROLLING_BY_INVITATION
This study tests a drug called Angiotensin II (Giapreza) in 30 children under 18 with life-threatening low blood pressure (vasodilatory shock) that hasn't improved with fluids or standard medicines. The goal is to see if the drug can safely raise blood pressure and reduce the nee…
Phase: PHASE4 • Sponsor: Todd Sweberg • Aim: Disease control
Last updated May 18, 2026 11:59 UTC